Activyl

RSS

indoxacarb

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 05/04/2019

Authorisation details

Product details
Name
Activyl
Agency product number
EMEA/V/C/000163
Active substance
indoxacarb
International non-proprietary name (INN) or common name
indoxacarb
Species
  • Dogs
  • Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP53AX27
Publication details
Marketing-authorisation holder
Intervet International BV
Revision
8
Date of issue of marketing authorisation valid throughout the European Union
18/02/2011
Contact address
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Product information

06/03/2019 Activyl - EMEA/V/C/000163 - IG/1043/0015

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

  • Ectoparasiticides for topical use, incl. insecticides

  • indoxacarb

Therapeutic indication

Treatment and prevention of flea infestation.

For dogs and cats: Treatment and prevention of flea infestation.

The veterinary medicinal product can be used as part of a treatment strategy for flea-allergy dermatitis. Developing stages of fleas in the pet's immediate surroundings are killed following contact with Activyl-treated pets.

Assessment history

How useful was this page?

Add your rating
Average
2 ratings